Thomas Jefferson University Hospital, Medical Oncology, Philadelphia, PA 19107, United States
Abstract:
A significant subset of head and neck carcinomas are infected with human papilloma virus; prophylactic vaccines can prevent such HPV+ cancers but are ineffective for invasive HPV+ cancers. We intend to make them therapeutic by means of systemic T regulatory cell depletion.